OrbiMed’s $4.3 Billion Funding Round

Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented OrbiMed on the transaction. OrbiMed announced it has raised more than $4.3 billion in commitments for its latest private investment...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

OrbiMed’s $125 Million Debt Financing

Covington & Burling advised OrbiMed on the deal. OrbiMed announced its $125 million debt financing with Verrica Pharmaceuticals, a dermatology therapeutics company developing medications for skin diseases...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here